ENDOSTENT Sirolimus-Eluting Coronary Stent System
The ENDOSTENT Sirolimus-Eluting Coronary Stent System is engineered to advance coronary interventions with a focus on early endothelialization and effective drug delivery. Featuring ultra-thin struts (63 μm) that minimize recoil and provide high radial strength, this stent ensures optimal vessel support and reduced foreshortening (<2%). The stent is coated with sirolimus, with a precise 6 μm thickness for controlled, sustained drug release over 90 to 120 days, promoting long-term vessel patency. Available in a range of diameters(2.25 to 4.00 mm) and lengths(10 to 48 mm), the ENDOSTENT offers versatile sizing to accommodate various anatomical needs.Its design includes both open and closed cell configurations to enhance flexibility and conformability.
Technical Specification
ENDOSTENT Sirolimus-Eluting Coronary Stent System
Available Stent Lengths
10, 13, 15, 18, 20, 24, 28, 32, 36, 40, 44, 48 mm
Available Stent Diameters
2.25, 2.50, 2.75, 3.00, 3.50, 4.00 mm
Stent Material
L605 Cobalt-Chromium (Co-Cr) Alloy
Stent Design
Open and closed cell design
Stent Platform
Bio-compatible polymer (PLGA carrier)
Stent Foreshortening
<2%
Stent Recoil
<4%
Stent Strut Thickness
63 μm
Bulge Strut Width
105 μm (strut)
Radial Strut Width
62.5 μm (hinge)
Connecting Strut Width
45 μm
Drug
Sirolimus
Coating Thickness
6 μm
Loading Density
1.2 ± 0.2 μg/mm²
Nominal Pressure
8 Bar
Rated Burst Pressure
16 Bar
Guidewire Compatibility
0.014”
Guiding Catheter Compatibility
5F
Delivery System
Monorail rapid exchange
Tip Entry Profile
0.018”
Proximal Shaft Diameter
0.76 mm
Distal Shaft Diameter
0.89 mm
Usable Catheter Length
100 mm, 245 mm, 900 mm, 1414 mm
Product Description
The ENDOSTENT Sirolimus-Eluting Coronary Stent System is engineered to enhance coronary interventions with advanced drug-eluting technology. It utilizes ultra-thin struts (63 μm) for early endothelialization and reduced stent recoil, with a high radial strength to maintain vessel patency. The stent's design includes both open and closed cell configurations, and it comes in various lengths and diameters to suit different anatomical needs.
The drug coating features sirolimus with a precise 6 μm thickness and a loading density of 1.2 ± 0.2 μg/mm², providing controlled drug release over time. The system is designed with minimal foreshortening (<2%) and high radial strength, ensuring stability and durability within the vessel.
Technical specifications include compatibility with 0.014” guidewires and 5F guiding catheters, a nominal pressure of 8 Bar, and a rated burst pressure of 16 Bar. The stent's delivery system is a monorail rapid exchange type, with a tip entry profile of 0.018” and available in multiple sizes to fit various clinical scenarios.
